Semaglutide Weight Loss in Ashland, OR
If you’ve been fighting your weight for years — trying diets that work temporarily, exercise routines that don’t stick, supplements that promise everything and deliver nothing — you’re not failing. Your biology has been working against you. And for the first time in the history of medical aesthetics and weight management, there are medications that work with your biology instead of against it.
Schedule a weight loss consultation — it’s a conversation about your goals, not a sales pitch.
Semaglutide and tirzepatide are GLP-1 receptor agonist medications that fundamentally change how your body regulates hunger, fullness, and fat storage. Clinical trials have shown average weight loss of 15-17% of body weight with semaglutide and up to 20-25% with tirzepatide — numbers that were previously only achievable through bariatric surgery. And unlike surgery, these are weekly injections you can start, adjust, and stop on your own terms.
At Illume Aesthetics, we offer both semaglutide and tirzepatide, supervised by our medical team. But we do something most weight loss clinics don’t — we also address what happens to your face and body after the weight comes off. Because losing weight is only half the equation. Looking and feeling like yourself at your new weight is the other half.
What Is Semaglutide and How Does It Work?
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist — a class of medication that mimics a hormone your gut naturally produces after eating. Here’s what it does:
Suppresses appetite at the brain level. GLP-1 receptors exist in the hypothalamus, the area of your brain that controls hunger and satiety. When semaglutide activates these receptors, you feel genuinely less hungry — not through willpower, but through a shift in the hormonal signals your brain receives.
Slows gastric emptying. Food stays in your stomach longer, so you feel full sooner during meals and stay satisfied longer afterward. Patients consistently describe eating half of what they used to and feeling completely satisfied.
Improves insulin sensitivity. Semaglutide was originally developed for type 2 diabetes (under the brand name Ozempic) before its weight loss effects proved so significant that it was approved specifically for weight management under the brand name Wegovy.
The clinical data is remarkable. In the landmark STEP clinical trials — the largest weight loss medication trials ever conducted — participants on semaglutide 2.4mg lost an average of 14.9% of their body weight over 68 weeks. 86% of participants lost at least 5%, 69% lost at least 10%, and over half lost 15% or more. For a 200-pound person, that’s 30+ pounds. With the addition of behavioral therapy (STEP 3), the average reached 16%. For context, the previous best-in-class weight loss medication achieved only 5-7% — semaglutide nearly tripled it.
This isn’t a diet pill. It’s a medical intervention that addresses the biological systems that make sustained weight loss so difficult for so many people. And it works.
Semaglutide vs Tirzepatide — We Offer Both
We carry both major GLP-1 medications because different patients respond differently:
Semaglutide (Wegovy / Ozempic) — The first GLP-1 to transform the weight loss landscape. Targets the GLP-1 receptor. FDA-approved specifically for weight management (Wegovy) and type 2 diabetes (Ozempic). Average weight loss: 15-17% of body weight.
Tirzepatide (Zepbound / Mounjaro) — The next generation. A dual GIP/GLP-1 receptor agonist, meaning it activates two incretin pathways instead of one. In the SURMOUNT trials, tirzepatide achieved average weight loss of 20-25% of body weight — the highest ever recorded for a non-surgical treatment. FDA-approved for weight management (Zepbound) and type 2 diabetes (Mounjaro).
| Semaglutide | Tirzepatide | |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GIP + GLP-1 receptor agonist |
| Brand names | Wegovy (weight loss), Ozempic (diabetes) | Zepbound (weight loss), Mounjaro (diabetes) |
| Average weight loss | 15-17% of body weight | 20-25% of body weight |
| Injection frequency | Weekly | Weekly |
| FDA approved for weight loss | Yes (Wegovy) | Yes (Zepbound) |
Which one is right for you? Your provider will recommend one based on your weight loss goals, health history, insurance coverage, and how your body responds. Some patients start with semaglutide and transition to tirzepatide if they plateau. Others do better on one from the start. The consultation is where we figure that out.
Semaglutide Before and After — What to Expect
Weight loss with GLP-1 medications is steady and progressive — not overnight. Here’s a realistic timeline:
- Weeks 1-4 (starting dose): Most patients notice reduced appetite and earlier fullness. Weight loss may be minimal (1-3 lbs) as your body adjusts to the medication.
- Weeks 4-12 (dose escalation): As your dose increases, appetite suppression becomes more noticeable. Most patients lose 5-10% of body weight during this phase.
- Months 3-6: This is where the transformation becomes visible. Patients in clinical trials averaged 10-12% body weight loss by month 6.
- Months 6-12+: Continued weight loss toward your goal. Most patients reach maximum benefit between 12-16 months. STEP trial participants averaged 15-17% total body weight loss at 68 weeks.
The numbers from clinical trials are averages — some patients lose significantly more, others less. Your result depends on your starting point, your dose, how consistently you take the medication, and the lifestyle changes you make alongside it. GLP-1 medications work best when combined with improved nutrition and regular movement — they’re not a substitute for those things, but they make them dramatically easier.
See more results in our before and after gallery.
Who Qualifies for GLP-1 Weight Loss?
Not everyone is a candidate for semaglutide or tirzepatide. During your consultation, your provider will review your medical history and determine whether GLP-1 therapy is appropriate for you.
General eligibility:
- BMI of 30 or greater (clinically defined as obesity), OR
- BMI of 27 or greater with at least one weight-related condition — such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea
Who should NOT take GLP-1 medications:
- Personal or family history of medullary thyroid carcinoma (MTC)
- History of Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- History of pancreatitis
- Pregnant or breastfeeding patients
- Patients with severe gastrointestinal disease
Our screening process: Your consultation includes a thorough health history review, current medication assessment, and discussion of your weight loss goals. We don’t prescribe GLP-1 medications to patients who aren’t appropriate candidates — your safety comes first, always.
The Treatment Protocol
GLP-1 treatment at Illume follows a structured, medically supervised protocol:
How the injections work
Semaglutide and tirzepatide are both weekly subcutaneous injections — a small needle injected just under the skin, typically in the abdomen, thigh, or upper arm. Most patients self-inject at home after being trained by their provider. The injection itself takes seconds.
Dose escalation schedule
Both medications follow a gradual dose escalation to minimize side effects:
Semaglutide: Starting at 0.25mg weekly, increasing every 4 weeks through 0.5mg → 1.0mg → 1.7mg → the maintenance dose of 2.4mg weekly. The escalation takes about 16-20 weeks.
Tirzepatide: Starting at 2.5mg weekly, increasing every 4 weeks through 5mg → 7.5mg → 10mg → 12.5mg → up to 15mg weekly. The escalation takes about 20-24 weeks.
What your appointments look like
- Initial consultation: Health history, eligibility screening, goal setting, medication selection, prescribing
- Monthly check-ins: Weight tracking, side effect management, dose adjustments, nutrition and lifestyle guidance
- Ongoing support: Your provider is available between appointments for questions, side effect management, and encouragement
This isn’t a “here’s your prescription, good luck” program. We stay with you through the entire process.
Side Effects and How We Manage Them
GLP-1 medications are effective because they change how your body processes food — and that means your digestive system needs time to adjust. Side effects are common, especially during dose escalation, but they’re manageable and typically decrease over time.
Gastrointestinal effects (most common):
- Nausea (44%) — The most frequently reported side effect. Usually worst during the first few weeks at each new dose and improves as your body adjusts — median duration is about 8 days per dose increase. Eating smaller meals, avoiding greasy or heavy foods, and staying hydrated helps significantly.
- Diarrhea (30%) — Common, especially during dose escalation. Usually resolves within a few days at each new dose level.
- Constipation (24%) — Expected as gastric emptying slows. Increased fiber, water intake, and over-the-counter remedies usually resolve it.
- Vomiting (25%) — More common during the early escalation phase. Typically resolves as your body adjusts.
- Decreased appetite — This is actually the mechanism of action, not a side effect. But some patients find it disorienting at first when they genuinely don’t feel hungry.
Less common effects:
- Headache, fatigue, dizziness (usually transient during dose escalation)
- Injection site reactions (mild redness or itching)
Serious but rare: Pancreatitis, gallbladder problems (associated with rapid weight loss from any cause), thyroid C-cell tumors (observed in animal studies — the reason for the MTC/MEN2 screening)
How we manage side effects: Slow dose escalation is the most effective prevention. If side effects are significant at a particular dose, we hold at that level longer before increasing, or we adjust timing and eating patterns. Your provider is available between appointments to troubleshoot — you’re never left to figure it out alone.
Foods to Avoid on Semaglutide
While there’s no strict “semaglutide diet,” certain foods tend to worsen GI side effects:
- Greasy, fried, and high-fat foods — harder to digest with slowed gastric emptying
- Large, heavy meals — eat smaller portions more frequently instead
- Excessive sugar and simple carbs — can cause blood sugar fluctuations
- Carbonated drinks — contribute to bloating
- Alcohol — can worsen nausea and is metabolized differently on GLP-1 medications; discuss with your provider
Focus on lean protein, vegetables, whole grains, and hydration. Many patients find that the medication naturally steers them toward healthier food choices because heavy, greasy meals simply don’t feel good anymore.
“Ozempic Face” and Body Changes After Weight Loss
Here’s the conversation most weight loss clinics skip entirely — and it’s one of the most important.
When you lose 30, 40, 50 or more pounds, your body changes in ways that go beyond the number on the scale. And some of those changes aren’t what you expected:
Facial volume loss (“Ozempic face”): Rapid weight loss from any cause — GLP-1 medications, surgery, or diet — can deplete the fat pads in your face, making you look gaunt, hollow, or older than you did before you lost the weight. Your cheeks flatten, your temples hollow, your nasolabial folds deepen. Nearly half of GLP-1 patients report noticeable facial changes within 3-6 months of treatment. You’ve achieved your goal weight, but your face tells a different story.
Skin laxity: Skin that was stretched over a larger frame doesn’t always bounce back, especially after significant weight loss in patients over 35. Loose skin on the abdomen, arms, and thighs is common.
Muscle loss: Research shows that up to 39% of the total weight lost on GLP-1 medications can come from lean muscle mass rather than fat — a significant proportion that most weight loss programs fail to address. Without resistance training and adequate protein intake, muscle loss can leave you lighter but weaker — and can contribute to the “deflated” look.
This is where Illume is different
Most semaglutide clinics hand you a prescription and weigh you monthly. We’re a full-service aesthetic practice — which means we don’t just help you lose the weight, we help you look and feel like yourself at your new weight.
For facial volume loss: Sculptra stimulates your body to rebuild the collagen and volume your face lost. Dermal fillers restore precise contour to cheeks, jawline, and temples. Our facial balancing approach combines both for comprehensive restoration.
For body concerns: Body contouring can address stubborn areas that don’t respond to weight loss alone.
For hormonal health: Weight loss can affect hormone levels. Our hormone therapy services address hormonal imbalances that may emerge or persist through your weight loss journey.
This integrated approach — weight loss plus aesthetic restoration — is something a telehealth weight loss startup or pharmacy counter simply can’t offer. It’s the full picture.
How Much Does Semaglutide Cost?
GLP-1 medication cost depends on which medication your provider prescribes and your insurance coverage.
Wegovy and Zepbound are manufactured by Novo Nordisk and Eli Lilly respectively. Both are FDA-approved with standardized dosing. Some insurance plans cover these medications for patients who meet BMI criteria — coverage varies by plan and prior authorization is typically required.
For patients paying out of pocket: Manufacturer savings programs have made GLP-1 medications significantly more accessible than their list prices suggest. NovoCare (Wegovy) offers subscription pricing that brings monthly costs well below the $1,000+ list price. Your provider will walk you through the available savings programs during your consultation so you know the real cost, not just the sticker price.
Putting the investment in perspective
The surgical alternative to GLP-1 weight loss is bariatric surgery — and the cost difference is significant. A gastric sleeve procedure averages $15,000 to $25,000. Gastric bypass runs $20,000 to $35,000. Both require general anesthesia, hospital stays, permanent anatomical changes, weeks of recovery, and lifelong dietary restrictions. Bariatric surgery is the right choice for some patients with severe obesity — but for patients who qualify for GLP-1 therapy, injectable medications achieve comparable results without surgery, without hospitalization, and without permanent changes to your anatomy.
The other comparison worth making is what obesity costs over time — in medications for blood pressure, cholesterol, and diabetes; in reduced mobility and quality of life; in the emotional weight of carrying more than your frame was designed for. GLP-1 treatment is an investment that pays dividends across every dimension of health.
During your consultation, your provider will give you specific pricing and walk you through insurance and savings program options so you can plan accordingly. We also offer financing options and our IllumèNaughty Beauty Bank membership includes member pricing on medical weight loss programs.
What Happens When You Stop Semaglutide?
This is the question everyone asks — and honesty here is more important than comfort.
The data: Clinical studies show that patients who discontinue GLP-1 medications without a maintenance strategy regain approximately two-thirds of the weight they lost within one year. This isn’t because the medication failed — it’s because the biological factors that caused the weight gain in the first place (hormone levels, appetite regulation, metabolic set points) are still present.
The reality: For many patients, GLP-1 therapy is not a short-term fix. It’s an ongoing medication, similar to blood pressure or cholesterol medication — you take it because the underlying condition benefits from continued treatment.
Our approach:
- Build the foundation while you’re on the medication. GLP-1 medications make it dramatically easier to adopt healthier eating habits, increase physical activity, and build muscle. These lifestyle changes are the foundation that helps sustain results if you eventually taper off.
- Consider a maintenance dose. Rather than stopping completely, many patients transition to a lower maintenance dose after reaching their goal weight. This sustains the appetite regulation benefits at a lower cost and with fewer side effects.
- Regular monitoring. Whether you continue on medication or taper off, we monitor your weight, health markers, and how you’re feeling. If weight begins to creep back, we adjust the plan before you’re back where you started.
- Address the aesthetics proactively. The patients who feel best at their new weight — and stay most motivated to maintain it — are the ones who look as good as they feel. That’s where the aesthetic side of our practice becomes part of the weight loss strategy, not an afterthought.
Why Choose Illume for Medical Weight Loss
Medical oversight, not a subscription box. Your treatment is supervised by our medical team, not an algorithm. You have a provider who knows your history, adjusts your dose, manages your side effects, and holds you accountable.
Both medications available. We offer both semaglutide and tirzepatide. Your provider recommends the right medication for your goals, health profile, and budget — not the only thing we stock.
The aesthetics pipeline. This is what makes Illume genuinely different. When you lose significant weight and your face starts looking hollow, we don’t refer you out — we restore your facial volume with Sculptra, fillers, and facial balancing. When your body doesn’t match your new number, we offer body contouring. It’s one team, one practice, one relationship — from your first injection to your fully restored self.
Backed by hundreds of five-star reviews — Our patients trust us with treatments that take months to show full results. That trust is earned one outcome at a time.
Frequently Asked Questions
How quickly will I see results on semaglutide?
Most patients notice reduced appetite within the first 1-2 weeks. Visible weight loss typically begins within 4-8 weeks as your dose escalates. The most significant changes happen between months 3 and 12. Patients on tirzepatide may see faster initial results due to the dual receptor mechanism. Your provider will set realistic expectations based on your starting point and goals.
Can I drink alcohol on semaglutide?
Technically yes, but many patients find alcohol tolerance decreases significantly on GLP-1 medications. Alcohol can worsen nausea, and because gastric emptying is slower, alcohol stays in your system longer. Most providers recommend limiting alcohol intake, especially during dose escalation. Discuss your specific situation with your provider.
Will I lose muscle on semaglutide?
Studies show up to 39% of total weight lost on GLP-1 medications can be lean muscle mass rather than fat. The best mitigation strategies are adequate protein intake (aim for 0.7-1g per pound of goal body weight daily) and resistance training at least twice per week. Your provider will discuss nutrition and exercise strategies during your check-ins. Building and preserving muscle is a key part of looking and feeling your best at your new weight.
Does insurance cover semaglutide for weight loss?
Some insurance plans cover Wegovy or Zepbound for weight loss when prescribed to patients who meet BMI criteria. Coverage varies widely by plan and prior authorization is typically required. Manufacturer savings programs (like NovoCare for Wegovy) can significantly reduce out-of-pocket costs even without insurance coverage. We’ll help you navigate your options during your consultation.
What foods should I eat on semaglutide?
Focus on lean protein (chicken, fish, eggs, legumes), vegetables, fruits, and whole grains. Eat smaller meals more frequently rather than large meals. Stay well hydrated — at least 64oz of water daily. Avoid greasy, fried, and high-fat foods that worsen GI side effects. Many patients find the medication naturally reduces cravings for processed foods and sugar — your taste preferences may shift without any conscious effort.
How is this different from Ozempic?
Ozempic and Wegovy are both semaglutide — the same molecule, made by the same manufacturer (Novo Nordisk). The difference is the FDA-approved indication: Ozempic is approved for type 2 diabetes, Wegovy is approved for weight management. The weight loss dose of semaglutide (2.4mg) is higher than the typical diabetes dose (up to 1.0mg). When we prescribe semaglutide for weight loss, we use the weight management dosing protocol.
Can I combine GLP-1 medication with other treatments?
Yes — and this is one of the advantages of working with a full-service aesthetic practice. Many of our semaglutide and tirzepatide patients also pursue treatments to address the aesthetic side effects of weight loss. Sculptra and dermal fillers restore facial volume. Body contouring addresses stubborn areas. Hormone therapy supports hormonal balance during significant body composition changes. Your provider can coordinate a comprehensive plan.
What’s the difference between semaglutide and tirzepatide?
Both are GLP-1 receptor agonists given as weekly injections. Semaglutide activates one receptor (GLP-1); tirzepatide activates two (GLP-1 and GIP). In clinical trials, tirzepatide produced greater average weight loss (20-25% of body weight vs. 15-17% for semaglutide). Some patients respond better to one than the other. Your provider will recommend the right choice based on your health profile, goals, and how you respond to treatment.
Start Your Weight Loss Consultation
The first step is a conversation. During your consultation, we’ll review your health history, discuss your goals, determine if GLP-1 therapy is right for you, and build a plan — including medication, dosing, nutrition guidance, and how we’ll address the aesthetic side of your transformation. No pressure, no commitment at the consultation.
Call us: (541) 631-8387
Illume Aesthetics 993 Siskiyou Blvd Suite 1 Ashland, OR 97520 Monday — Friday, 9am — 5pm